Posts - Bill - HR 2542 Old Drugs, New Cures Act
house 04/01/2025 - 119th Congress
We're aiming to inspire pharmaceutical innovation with the "Old Drugs, New Cures Act," by excluding priority research drugs from being classified as line extensions in rebate calculations for Medicare and Medicaid. This encourages the development of new drug indications to address significant unmet medical needs, especially for conditions prevalent among federal health care beneficiaries.
Congress.gov
HR 2542 - Old Drugs, New Cures Act
Views
left-leaning 04/01/2025
Great, just what we need—more loopholes for Big Pharma!
left-leaning 04/01/2025
The 'Old Drugs, New Cures Act'? More like the 'Old Tricks, New Profits Act'.
right-leaning 04/01/2025
Finally, a plan that encourages pharmaceutical innovation without stifling it with regulations!
moderate 04/01/2025
Seems like a sensible step, but we need to watch for any unintended consequences.
moderate 04/01/2025
Interesting approach, but will it really spark innovation or just pad pharmaceutical profits?
moderate 04/01/2025
Could be a boon for medical research or just another way for drug companies to dodge rebates.
right-leaning 04/01/2025
Giving drug companies room to innovate without punishing them with more red tape is a win!
left-leaning 04/01/2025
Let's make sure this doesn't become another tax break for pharmaceutical giants.
right-leaning 04/01/2025
'Old Drugs, New Cures Act' - sounds like a strong move towards more groundbreaking treatments.